174 related articles for article (PubMed ID: 23891908)
21. Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.
Krikke M; Klomberg RCW; van der Veer E; Tesselaar K; Verhaar HJJ; Hoepelman AIM; Arends JE
Neth J Med; 2017 May; 75(4):138-144. PubMed ID: 28522769
[TBL] [Abstract][Full Text] [Related]
22. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
Carr A; Miller J; Eisman JA; Cooper DA
AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
[TBL] [Abstract][Full Text] [Related]
23. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
24. Risk factors of osteopenia in HIV-infected women: no role of antiretroviral therapy.
Libois A; Clumeck N; Kabeya K; Gerard M; De Wit S; Poll B; Tondeur M; Rozenberg S
Maturitas; 2010 Jan; 65(1):51-4. PubMed ID: 19939594
[TBL] [Abstract][Full Text] [Related]
25. Serum leptin and bone metabolism in HIV patients treated with highly active antiretroviral therapy.
Madeddu G; Spanu A; Chessa F; Calia GM; Lovigu C; Mannazzu M; Falchi A; Sanna D; Mura MS; Madeddu G
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):290-301. PubMed ID: 18596668
[TBL] [Abstract][Full Text] [Related]
26. Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology.
Kemink SA; Hermus AR; Swinkels LM; Lutterman JA; Smals AG
J Endocrinol Invest; 2000 May; 23(5):295-303. PubMed ID: 10882147
[TBL] [Abstract][Full Text] [Related]
27. Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients.
Fernández-Rivera J; García R; Lozano F; Macías J; García-García JA; Mira JA; Corzo JE; Gómez-Mateos J; Rueda A; Sánchez-Burson J; Pineda JA
HIV Clin Trials; 2003; 4(5):337-46. PubMed ID: 14583850
[TBL] [Abstract][Full Text] [Related]
28. Prevalence and risk factors for low bone mineral density in antiretroviral therapy-naive HIV-infected young men.
Paccou J; Viget N; Drumez E; Cortet B; Robineau O
Med Mal Infect; 2018 Oct; 48(7):442-448. PubMed ID: 29699830
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population.
Tomazic J; Ul K; Volcansek G; Gorensek S; Pfeifer M; Karner P; Prezelj J; Vidmar G; Vidmar L
Wien Klin Wochenschr; 2007; 119(21-22):639-46. PubMed ID: 18043884
[TBL] [Abstract][Full Text] [Related]
30. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
[TBL] [Abstract][Full Text] [Related]
31. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
[TBL] [Abstract][Full Text] [Related]
32. A longer time of exposure to antiretroviral therapy improves selenium levels.
de Menezes Barbosa EG; Júnior FB; Machado AA; Navarro AM
Clin Nutr; 2015 Apr; 34(2):248-51. PubMed ID: 24746975
[TBL] [Abstract][Full Text] [Related]
33. Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavir.
Rivas P; Górgolas M; García-Delgado R; Díaz-Curiel M; Goyenechea A; Fernández-Guerrero ML
HIV Med; 2008 Feb; 9(2):89-95. PubMed ID: 18093130
[TBL] [Abstract][Full Text] [Related]
34. Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans.
Dave JA; Cohen K; Micklesfield LK; Maartens G; Levitt NS
PLoS One; 2015; 10(12):e0144286. PubMed ID: 26633015
[TBL] [Abstract][Full Text] [Related]
35. Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART).
Teichmann J; Lange U; Discher T; Lohmeyer J; Stracke H; Bretzel RG
Eur J Med Res; 2009; 14(2):59-64. PubMed ID: 19258214
[TBL] [Abstract][Full Text] [Related]
36. Reduced bone mineral density among HIV-infected, virologically controlled young men: prevalence and associated factors.
Shaiykova A; Pasquet A; Goujard C; Lion G; Durand E; Bayan T; Lachâtre M; Choisy P; Ajana F; Bourdic K; Viget N; Riff B; Quertainmont Y; Cortet B; Boufassa F; Chéret A
AIDS; 2018 Nov; 32(18):2689-2696. PubMed ID: 30234605
[TBL] [Abstract][Full Text] [Related]
37. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.
Brown TT; Qaqish RB
AIDS; 2006 Nov; 20(17):2165-74. PubMed ID: 17086056
[TBL] [Abstract][Full Text] [Related]
38. Switching to darunavir/ritonavir monotherapy vs. triple-therapy on body fat redistribution and bone mass in HIV-infected adults: the Monarch randomized controlled trial.
Guaraldi G; Zona S; Cossarizza A; Vernacotola L; Carli F; Lattanzi A; Nardini G; Orlando G; Garlassi E; Termini R; Garau M
Int J STD AIDS; 2014 Mar; 25(3):207-12. PubMed ID: 24216034
[TBL] [Abstract][Full Text] [Related]
39. Low bone mineral density in HIV-positive young Italians and migrants.
Cascio A; Colomba C; Di Carlo P; Serra N; Lo Re G; Gambino A; Lo Casto A; Guglielmi G; Veronese N; Lagalla R; Sergi C
PLoS One; 2020; 15(9):e0237984. PubMed ID: 32881882
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of bone mineral density and selected metabolic markers of bone in boys with constitutional delay of growth and puberty].
Krupa B
Ann Acad Med Stetin; 2000; 46():165-76. PubMed ID: 11712302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
